More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$120.88B
EPS
9.39
P/E ratio
28.6
Price to sales
4.12
Dividend yield
1.109%
Beta
0.784042
Previous close
$310.72
Today's open
$309.12
Day's range
$308 - $319.33
52 week range
$267 - $389.33
show more
CEO
Kevin A. Lobo
Employees
56000
Headquarters
Portage, MI
Exchange
New York Stock Exchange
Shares outstanding
380691004
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
Stryker Corporation (SYK) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Stryker Corporation (SYK) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Seeking Alpha • Nov 17, 2026

GEHC or SYK: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Products sector might want to consider either GE HealthCare Technologies (GEHC) or Stryker (SYK). But which of these two companies is the best option for those looking for undervalued stocks?
Zacks Investment Research • Nov 16, 2026

Stryker announces intention to nominate Jim Davis to board of directors
Portage, MI, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Stryker announces intention to nominate Jim Davis to board of directors Stryker (NYSE:SYK) announced that its board of directors has nominated Jim Davis for election to the company's board, effective Jan. 1, 2027. Jim serves as Chairman, CEO and President of Quest Diagnostics.
GlobeNewsWire • Nov 9, 2026

3 Medical Device Stocks That Keep Raising Dividends. One Just Hit 55 Years
Hospitals reorder syringes, sensors, and implants whether the economy booms or stalls, and three device makers turn that habit into payouts that grow every year.
24/7 Wall Street • Nov 7, 2026

69 Dividend Champions Ranked By Quality Scores (November 2026)
I present 69 Dividend Champions with Dividend Safety scores of 8+ and rank them using my 9F Quality Scores system. Twenty-two featured Dividend Champions are undervalued, while 21 are overvalued. Forty-nine have quality scores ≥ 7.0, indicating high quality. Top candidates by style: BRO and BMI for growth; BRO, BMI, and RGLD (below $262) for total return; CTBI for income; CAT for past performance.
Seeking Alpha • Nov 7, 2026

Diamond Hill Large Cap Fund Q3 2026 Portfolio Update
The Fund returned 3.18% compared to a 2.61% return for the Russell 1000 Value Index. Key contributors include Microsoft, Salesforce and Thermo Fisher Scientific. Key detractors include Aon, Carrier Global and Builders FirstSource.
Seeking Alpha • Nov 6, 2026

Stryker Analysts Cut Their Forecasts Following Downbeat Q3 Earnings
Stryker Corp. (NYSE:SYK) on Thursday posted weaker-than-expected third-quarter results.
Benzinga • Oct 30, 2026

Stryker's Guidance Cut Rattles Investors: What It Really Says About 2027
Medical device maker Stryker (NYSE:SYK | SYK Price Prediction) shares fell about 10% before the open Friday to $279.98, compared with Thursday's close of $311.75. The quarter missed expectations on both lines.
24/7 Wall Street • Oct 30, 2026

What Stryker (SYK) Said on Its Q3 Earnings Call
Stryker NYSE: SYK reported third-quarter organic sales growth of 7.7% and adjusted earnings per share of $3.52, while lowering its full-year outlook to reflect a slowdown in hip and knee procedures, lingering peripheral vascular supply constraints and execution risks tied to capital equipment sales.
MarketBeat • Oct 30, 2026

SYK Stock Skids as Q3 Earnings and Sales Miss & 2026 Outlook Cut
Stryker shares plunge 11.8% after Q3 earnings and sales miss estimates, prompting a 2026 outlook cut amid weak joint procedures and execution challenges.
Zacks Investment Research • Oct 30, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Stryker Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.